Alvin Zipursky

Q: What Schools Are Affiliated With Alvin Zipursky

Alvin Zipursky is affiliated with the following schools: McMaster University, University of Manitoba, University of Toronto

Alvin Zipursky's AcademicInfluence.com Rankings

Alvin Zipursky

Biology

#12871

World Rank

#16375

Historical Rank

Neuroscience

#2194

World Rank

#2255

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Alvin Zipursky Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alvin Zipursky's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Developing Nervous System: A Series of Review Articles: Neurobiology of Hypoxic-Ischemic Injury in the Developing Brain (2001) (421)
Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels (2013) (322)
GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. (2003) (289)
A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. (2006) (281)
Leukemia in Down syndrome: a review. (1992) (241)
Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21 (2003) (196)
Origins of leukaemia in children with Down syndrome (2005) (184)
Myelodysplasia and acute megakaryoblastic leukemia in Down's syndrome. (1994) (158)
The hematology of bacterial infections in premature infants. (1976) (147)
Leukemic reticuloendotheliosis. A failure of monocyte production. (1976) (146)
Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. (1997) (136)
Megakaryoblastic leukemia and Down's syndrome: a review. (1987) (132)
Neutrophil and band counts in the diagnosis of neonatal infections. (1974) (121)
THE TRANSPLACENTAL PASSAGE OF FOETAL RED BLOOD-CELLS AND THE PATHOGENESIS OF RH IMMUNISATION DURING PREGNANCY. (1963) (121)
Incidence and Treatment of Potentially Lethal Diseases in Transient Leukemia of Down Syndrome: Pediatric Oncology Group Study (2002) (120)
The pathogenesis and prevention of Rh immunization. (1967) (106)
Foetal erythrocytes in the maternal circulation. (1959) (105)
Cost-effectiveness of antepartum prevention of Rh immunization. (1984) (99)
Juvenile myelomonocytic leukemia and Noonan syndrome. (1999) (97)
Assessment of anemia in newborn infants. (1984) (92)
The Neurobiology and Consequences of Epilepsy in the Developing Brain (2001) (91)
PREVENTION OF VITAMIN K DEFICIENCY BLEEDING IN NEWBORNS (1999) (90)
Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. (1999) (83)
McMaster conference on prevention of Rh immunization. 28-30 September, 1977. (1979) (81)
Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. (1991) (78)
A global need for affordable neonatal jaundice technologies. (2011) (78)
Bleeding diathesis in Noonan syndrome: a common association. (1988) (76)
Thrombotic disease in newborn infants. (1984) (75)
THE EARLY APPEARING BILIRUBIN: EVIDENCE FOR TWO COMPONENTS. (1965) (74)
The global burden of Rh disease (2010) (72)
Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. (1992) (71)
A new variant translocation in acute promyelocytic leukaemia: molecular characterization and clinical correlation. (1996) (69)
Leukocyte density and volume in normal subjects and in patients with acute lymphoblastic leukemia. (1976) (67)
Cytogenetic and molecular studies of Down syndrome individuals with leukemia. (1995) (67)
Short‐course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP) (1998) (67)
Congenital abnormalities and childhood cancer (2005) (66)
The nonerythropoietic component of early bilirubin. (1968) (62)
Shunt Bilirubin: Evidence for Two Components (1963) (59)
TRANSPLACENTAL FOETAL HAEMORRHAGE AFTER PLACENTAL INJURY DURING DELIVERY OR AMNIOCENTESIS. (1963) (54)
Long‐term results of an ultra low‐dose cytarabine‐based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome (2006) (50)
Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years (2013) (50)
Transient Donath‐Landsteiner Haemolytic Anaemia (1981) (49)
The erythrocyte differential count in newborn infants. (1983) (47)
Setting global research priorities for integrated community case management (iCCM): Results from a CHNRI (Child Health and Nutrition Research Initiative) exercise (2014) (44)
The spectrum of ABO hemolytic disease of the newborn infant. (1979) (42)
A Study of the Early‐Labelled Fraction of Bile Pigment: The Effect of Altering Erythropoiesis on the Incorporation of [2‐14C] Glycine into Haem and Bilirubin * (1963) (41)
The in vitro metabolism of erythrocytes from newborn infants. (1960) (41)
Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics. (1996) (38)
Hydrops fetalis and neonatal leukemia in Down syndrome. (1996) (38)
Lack of Opsonization Potential of 11S Human Secretory γA 1 (1973) (37)
Primary Shunt Hyperbilirubinæmia (1962) (35)
The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome. (2000) (35)
Telomerase and the Benign and Malignant Megakaryoblastic Leukemias of Down Syndrome (2002) (34)
Concurrent RhGM‐CSF does not offset myelosuppression from intensive chemotherapy: Randomized placebo‐controlled study in childhood acute lymphoblastic leukemia (1994) (34)
Vitamin E absorption in small premature infants. (1979) (33)
THE ERYTHROCYTES OF THE NEWBORN INFANT. (1965) (33)
Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome (2004) (32)
Studies on copper metabolism. XXIV. Hypocupremia in infancy. (1958) (32)
Megakaryoblastic leukemia and Down's syndrome--a review. (1987) (31)
Essential thrombocythemia in children. (1999) (31)
Erythropoietin Therapy for Premature Infants: Cost without Benefit? (2000) (30)
A microhemagglutination-inhibition assay for the quantitation of fibrinogen breakdown products. (1968) (29)
Nutritional vitamin B12 deficiency in infancy: three case reports and a review of the literature. (1989) (29)
Pharmacokinetic determinants of 6‐mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia (1986) (29)
The haematology of bacterial infection in newborn infants. (1978) (29)
Ultrastructural studies of the megakaryoblastic leukemias of Down syndrome. (1995) (28)
Vitamin C-induced erythrocyte damage in premature infants. (1988) (28)
Diurnal variation in the pharmacokinetics and myelotoxicity of mercaptopurine in children with acute lymphocytic leukemia. (1990) (27)
Rh hemolytic disease of the newborn--the disease eradicated by immunology. (1977) (27)
Transient leukemia with extreme basophilia in a phenotypically normal infant with blast cells containing a pseudodiploid clone, 46,XY i(21)(q10). (1999) (27)
The Universal Prevention of Rh Immunization (1971) (26)
Transient leukemia followed by megakaryoblastic leukemia in a child with mosaic Down syndrome. (1995) (24)
THE DISTRIBUTION OF FETAL HEMOGLOBIN IN THE BLOOD OF NORMAL CHILDREN AND ADULTS (1962) (24)
Clinical and laboratory diagnosis of hemostatic disorders in newborn infants. (1979) (23)
An Antibody Defining a New Blood Group Antigen, Bua * (1963) (22)
The relationship of adenosine triphosphate concentration to erythrocyte aging. (1968) (22)
Improved survival in severe acquired aplastic anemia of childhood (2000) (22)
Oral vitamin E supplementation for the prevention of anemia in premature infants: a controlled trial. (1987) (22)
Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome. (1994) (21)
DIAGNOSTIC AMNIOCENTESIS AND FETAL-MATERNAL BLEEDING (1974) (21)
Pediatrics, war, and children. (2010) (20)
Transport of Phosphate into the Erythrocyte (1961) (20)
The reversibly sickled cell. (1993) (19)
A New European Editorial Office (2001) (19)
THE TRANSPLACENTAL PASSAGE OF FOETAL RED BLOOD CELLS AND THE PATHOGENESIS OF RH IMMUSISATION DURING PREGNANCY (1964) (19)
Characterization and molecular analysis of nondisjunction in 18 cases of trisomy 21 and leukemia (1992) (18)
The early bilirubin. (1966) (17)
Analysis of 6-mercaptopurine in serum or plasma using high performance liquid chromatography. (1985) (17)
Setting priorities for development of emerging interventions against childhood diarrhoea (2013) (16)
Global action plan for childhood diarrhoea: Developing research priorities (2013) (16)
Idiopathic thrombocytopenia and neutropenia in childhood. (1994) (16)
Pediatric Research Looks to the Future (2000) (16)
Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children (2020) (16)
Evaluation of a New Method for the Prevention of Neonatal Anemia (1989) (16)
Vitamin K at birth (1996) (15)
Leukemia in newborn infants with Down syndrome. (1993) (15)
The effect of abdominal radiation on spleen function: a study in children with Wilms' tumor. (1986) (15)
Massive transplacental hemorrhage: clinical manifestations in the newborn. (1975) (15)
Hereditary Spherocytosis: The Metabolism of Erythrocytes in the Peripheral Blood and in the Splenic Pulp (1974) (15)
The ingestion of IgG-sensitized erythrocytes by abnormal neutrophils. (1974) (15)
Reduction of platelet counts induced by mechanical ventilation in newborn infants. (1987) (14)
PHOSPHATE METABOLISM IN ERYTHROCYTES OF NORMAL HUMANS AND OF PATIENTS WITH HEREDITARY SPHEROCYTOSIS (1962) (14)
Susceptibility to Leukemia and Resistance to Solid Tumors in Down Syndrome (2000) (14)
TOXICITY OF LEUKAEMIA THERAPY IN CHILDREN WITH DOWN SYNDROME (1986) (13)
The pathogenesis of defective hemostasis in abruptio placentae. (1968) (13)
Rhesus disease: a global prevention strategy. (2018) (13)
Vitamin E deficiency anemia in newborn infants. (1984) (12)
Erythrocyte sodium transport in hereditary elliptocytosis. (1966) (12)
Factofatr V levels in the neonatal period. (1955) (12)
Does vitamin C cause hemolysis in premature newborn infants? Results of a multicenter double-blind, randomized, controlled trial. (1997) (11)
Idiopathic Heinz body hemolytic anemia in newborn infants. (1989) (11)
The quantitation of spherocytes in ABO hemolytic disease. (1979) (11)
GATA 1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome--a new tool with significant potential applications. (2005) (11)
A study of hemophilia. (1957) (11)
Sulfhydryl groups of the erythrocyte membrane and their relation to glycolysis and drug-induced hemolytic anemia. (1974) (11)
Congenital non-spherocytic hemolytic anemia. (1965) (11)
Neonatal Jaundice: Continuing Concern and Need for Research (2001) (10)
Fibrinolytic activity and fibrinogen split products in exercise proteinuria. (1971) (10)
Impact of Rhesus disease on the global problem of bilirubin-induced neurologic dysfunction. (2015) (10)
A new syndrome of familial aplastic anemia and chronic liver disease. (1997) (10)
Perforin Deficiency and Familial Hemophagocytic Lymphohistiocytosis (2001) (9)
ABO haemolytic disease of the new born. (1979) (9)
Mechanisms of hemolysis. (1982) (9)
Selective IgA Deficiency in Rh‐Negative Women (1974) (9)
The early-appearing bilirubin in ducks. (1966) (8)
Severe thrombocytopenia in sickle cell crisis. (1988) (8)
Maternal erythrocytes in the fetal circulation. The immunocytochemical identification of minor populations of erythrocytes. (1987) (7)
Antibodies to IGA in Pregnancy and in Recipient of Rho(D) Immune Globulin (Human) (1972) (7)
The Risk of Hematopoietic Growth Factor Therapy in Newborn Infants (2002) (7)
Rhesus disease: a major public health problem (2015) (6)
Preventing Rh Immunization (1968) (6)
THE ASSESSMENT OF ANEMIA IN SMALL PREMATURE INFANTS (1977) (6)
Sarcomas of soft tissue and bone in childhood. Proceedings of a symposium. Orlando, Florida, January 25-27, 1979. (1982) (6)
Low antithrombin III in neonatal shock: DIC or non-specific protein depletion? (1986) (6)
The Programme for Global Paediatric Research. (2011) (6)
Significance of Erythrocyte Sodium Flux in the Pathophysiology and Genetic Expression of Hereditary Spherocytosis (1971) (6)
A History of Pediatric Specialties (2002) (6)
PREVENTION OF VITAMIN K DEFICIENCY IN NEWBORNS (1999) (6)
Fetal Origin of Leukemia and Autologous Cord Blood Transfusions (2000) (6)
COMPARATIVE EFFECTS OF NITROGEN MUSTARD (HN2), CHLORAMBUCIL (CB 1348), AND BUSULPHAN (MYLERAN) ON THE PERIPHERAL BLOOD AND THE FERROKINETIC PATTERNS IN DOGS (1962) (5)
The Genetics of Childhood Disease and Development (2003) (5)
Studies of the pathogenesis and prevention of Rb-isoimmunization in pregnant women (1966) (5)
Disseminated intravascular coagulation masking neonatal hemophilia. (1986) (5)
FŒTAL HÆMOGLOBIN SYNTHESIS IN SOME HÆMOGLOBINOPATHIES (1961) (5)
VINCRISTINE TOXICITY (1985) (4)
Pediatric Research at the Threshold of the 21st Century (1999) (4)
Letter: Diagnostic amniocentesis and fetal-maternal bleeding. (1974) (4)
Nutritional vitamin B12 deficiency in infancy (1989) (4)
The conquest of Rh disease. (1978) (4)
ERYTHROCYTE METABOLISM IN GALACTOSEMIA. (1965) (4)
A Naturally Occurring Inhibitor of the First Stagc of Blood Coagulation (1960) (3)
THE ANTICOAGULANT ACTION OF POLYBRENE. (1965) (3)
Metabolic Abnormalities of Erythrocytes in the Hemolytic Anemias (1962) (3)
The Coagulation Defect in Hypervitaminosis A in Rats (1962) (3)
Effect of vitamin E therapy on blood coagulation tests in newborn infants. (1980) (3)
ERYTHROCYTE MORPHOLOGY IN NEWBORN INFANTS A NEW LOOK (1977) (3)
An abnormality in erythrocyte sodium transport in hereditary elliptocytosis (1965) (3)
The Programme for Global Paediatric Research (2005) (3)
Hematologic Problems in the Newborn, ed 2. Volume 4 in the series, Major Problems in Clinical Pediatrics, Alexander J Schaffer, consulting editor. (1972) (2)
1459 RANDOMIZED CONTROLLED TRIAL OF VIT. E. AND BRONCHOPULMONARY DYSPLASIA (BPD) (1981) (2)
Changes in circulating red cell volume during the first 6 weeks of life in very-low-birth-weight infants (2014) (1)
Health care delivery and the red blood cell. (1980) (1)
The distribution of fetal hemoglobin in various hematologic disorders (1962) (1)
SIMILAR DECREASE OF ANTITHROMBIN III (ATIII) AND ALBUMIN IN BIRTH ASPHYXIA AND PRESUMED DISSEMINATED INTRAVASCULAR COAGULATION (DIC) (1984) (1)
Vitamin E, sample size, and beta error. (1980) (1)
ERYTHROCYTE CREATINE LEVELS (EC) AND THE DIAGNOSIS OF HEMOLYTIC DISEASE IN NEWBORN INFANTS (HDN) (1984) (1)
Ethics and Responsibilities in Pediatric Research (1999) (1)
Tribute: The American Society of Pediatric Hematology/Oncology (ASPHO) 2012 distinguished career award goes to Dr. Victor Blanchette (2012) (1)
VAN DUZER MEMORIAL ORATION: THE EFFECT OF ARMED CONFLICT ON CHILD HEALTH AND DEVELOPMENT (2010) (1)
Telomerase, Immortality, and Cancer (2000) (1)
The quiet revolution in blood...transfusion therapy. (1979) (1)
Infants affected by Rh sensitization: A 2-year Canadian National Surveillance Study. (2020) (0)
myelodysplasia of Down syndrome Interphase cytogenetic analysis of in vivo differentiation in the (2011) (0)
TRANSPLACENTAL FOETAL HAMEMORRHAGE AFTER PLACENTAL INJURY DURING DELIVERY OR AMNIOCENTESIS (1964) (0)
Antihemophilic globulin (AHG) response to exercise for the detection of hemophilia A carriers (1971) (0)
HL-A genotype of patients with acute lymphoblastic leukaemia (2004) (0)
Congenital nonspherocytic bemolytic anemia (1964) (0)
Presenting clinical and laboratory features of transient myeloproliferative disorder (TMD) in neonates with Down syndrome (DS): a Pediatric Oncology Group Study (2000) (0)
A history of pediatric hematology/oncology in Canada. (1991) (0)
Medulloblastoma in children. Current prognostic factors (1989) (0)
F144. Behaviour of erythrocytic morphology in several pathologies (1995) (0)
Alterations in red cell structureand metabolism associated with rapid blood production: The stress reticulocyte (1964) (0)
Disseminated Intravascular Coagulation Complicating The Perinatal “Dropped-Dead” Syndrome: Lack Of Influence Of Cardio-PulmoNary Resuscitation (1981) (0)
Continuous intravenous infusion of morphine for the treatment of severe vaso-occlusive painful crises in children with sickle cell anemia (1991) (0)
Transient myeloproliferative disorder (TMD) in neonates with Down syndrome (DS); early death and hepatic failure: a Pediatric Oncology Group Study (2000) (0)
The spectrum of ABO hemolytic newborn infant disease of the (1979) (0)
SUBOPTIMAL MANAGEMENT OF PAIN CRISES IN SICKLE CELL DISEASE: PROSPECTIVE OBSERVATIONS (1990) (0)
Ethics in Pediatric Research (2000) (0)
FACTOR V LEVELS IN THE NEONATAL PERIOD (1955) (0)
Leukemia-Initiating Cells in Acute Megakaryoblastic Leukemia and Transient Leukemia of Down Syndrome. (2007) (0)
Preparation of Human Fibrinogen Free of Plasminogen by Immunoadsorption (1972) (0)
A study of bilirubin synthesis in a human with a bile fistula. (1962) (0)
Long-term results of a low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukemia and myelodysplastic syndrome in children with Down syndrome (2005) (0)
Cytogenetic andMolecular Studies ofDown Syndrome Individuals withLeukemia (1995) (0)
Launch of Articles in Press (2002) (0)
ASSESSMENT OF ANEMIA IN NEWBORN INFANTS 123 (2006) (0)
RED CELL CHANGES IN NEONATAL SEPSIS (1987) (0)
Hematology and oncology at the Hospital for Sick Children. (1996) (0)
484 CLINICAL DISAGREEMENT IN THE ASSESSMENT OF BPD IN A CLINICAL TRIAL (1981) (0)
ACUTE MEGAKARYOBLASTIC LEUKEMIA (AMKL): A UNIQUE ASSOCIATION WITH DOWN'S SYNDROME (DS) (1987) (0)
Cytogenetic and molecular studies of Down syndrome individuals with transient leukemia (1994) (0)
Reflections on Pediatric Research (2003) (0)
The pathogenesis and prevention of Rh immunization in pregnancy. (1968) (0)
786 IMMUNO-IDENTIFICATION OF HUMAN FETAL FIBRINOGEN (1981) (0)
577 PHYSIOLOGICAL COAGULATION STUDIES IN INFANTS 24–31 WKS GESTATION (1978) (0)
Evaluation of erythrocytic morphology in vasculopatic subjects with and without diabetes: Comparison with blood viscosity and intracellular calcium (1995) (0)
614 Megakaryocyte Growth and Development Factor (MGDF) and the growth and differentiation of the leukemic cells of Down Syndrome patients with megakaryoblastic leukemia (1997) (0)
The metabolism of erythrocytes sequestered in the splenic pulp of patients with hereditary spherocytosis (1965) (0)
Haemorrhagic disease and anaemia of the newborn (1983) (0)
Erythrocyte Sodium Flux in Hereditary Spherocytosis: Its Significance (1970) (0)
Dr. Maureen Andrew: 1952–2001 (2001) (0)
HEMATOLOGY AND ONCOLOGY FIRST SESSION May 17, 1973, 9:00 A.M. Hilton Plaza Room (1973) (0)
Prevention of Rh immunization. (1975) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alvin Zipursky?

Alvin Zipursky is affiliated with the following schools:

Alvin Zipursky's Academic­Influence.com Rankings

Why Is Alvin Zipursky Influential?

Alvin Zipursky's Published Works

Published Works

What Schools Are Affiliated With Alvin Zipursky?

Alvin Zipursky's AcademicInfluence.com Rankings